CompletedNot Applicable

Locally Delivered Whey Protein Nanoparticles Gel in Stage II Grade B Periodontitis

Egypt45 participantsStarted 2024-05-05

Plain-language summary

Aim of the current study is to evaluate radiographic and clinical alterations following topical application of CWP gel and CWP nanoparticles gel in stage II grade B periodontitis patients.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients will be selected to be systemically free with stage II periodontitis * having 3-4 mm interdental clinical attachment loss (CAL) at ≥2 nonadjacent teeth * maximum probing depth ≤5 mm Exclusion Criteria: * smokers * pregnant and lactating females * patients received any type of periodontal treatment in the past 6 months prior to examination * patients who used antibiotic or anti-inflammatory drugs or antioxidants within the 6 months preceding the beginning of the study

What they're measuring

Bone height:

Timeframe: 6-months

Mesiodistal (MD) and buccolingual (BL) bone defect width

Timeframe: 6-months

Trial details

NCT IDNCT06401798

SponsorKafrelsheikh University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Periodontitis Chronic Localized Slight trials